High-throughput TCR sequencing (HTS) detected T cell clones in 46 of 46 CTCL patients, which according to the authors was more sensitive and specific than TCRγ PCR, and successfully discriminated CTCL from benign inflammatory diseases. Here, TRGC1 is linked to primary cutaneous T-cell non-Hodgkin lymphoma.